I have shown that cyclic AMP stimulates sugar uptake in rat thymocytes. However, trypsin treatment, which increases rat thymocyte cyclic AMP concentration, fails to increase sugar uptake. The purpose of the present study is to examine this seeming inconsistency, and to evaluate further the function of trypsin. Mild trypsin treatment of rat thymocytes produced a dose-related increase in cellular cyclic AMP concentration. Trypsin produced the same proportionate increase in cyclic AMP concentration in the presence or absence of optimal concentrations of the phosphodiesterase inhibitor 3-isobutyl-l-methylxanthine, which suggests that trypsin acts to increase thymocyte cyclic AMP concentration by stimulating adenylate cyclase activity. Trypsin at concentrations of 0.3 mg/ml and less had no effect on the uptake of the glucose analogue 2-deoxy-D-glucose (2-DG), whereas at concentrations of 1 mg/ml and higher trypsin produced a small, dose-related, decrease in basal 2-DG uptake, becoming significantly lower than control values only at 5 mg/ml (-22.7%, P < 0.05). Thymocyte sugar transporters, characterized by means of cytochalasin B binding, consist of a single class of sites with an apparent KD of 0.15 /LM and maximum binding capacity of 2.73 pmol/20 x 106 cells (8.4 x 104 sites/thymocyte). Trypsin produced a dose-related decrease in the sugar-displaceable binding of cytochalasin B, so that at 5 mg of trypsin/ml the number of sugar transporters was decreased by approx. 50% . Thus trypsin treatment of rat thymocytes on the one hand increases cellular cyclic AMP concentration, which itself potentiates 2-DG uptake, and on the other hand decreases the number of sugar transporters, which itself decreases cellular sugar uptake, indicating that the apparent effect of trypsin on thymocyte 2-DG uptake is the result of the balance of its effects on these two systems.
INTRODUCTION
We have demonstrated in rat thymocytes that an increase in cellular cyclic AMP concentration results in an increase in the uptake of the glucose analogue 2-deoxy-D-glucose by the cell [1, 2] . We have further shown that mild trypsin treatment of freshly isolated rate thymocytes, which does not damage the cell [3] , produces a progressive dose-related increase in cellular cyclic AMP concentration, which is independent of Ca2+ and calmodulin [3, 4] . This effect of trypsin, however, is not accompanied by an increase in 2-DG uptake, but 5 mg oftrypsin/ml, the highest concentration used, produced a small decrease in thymocyte 2-DG uptake [3] . This seems to be inconsistent with our hypothesis, that in rat thymocytes an increase in cellular cyclic AMP concentration is associated with an increase in 2-DG uptake. The purpose of the present study is to clarify this dilemma, and to elucidate further the effect of trypsin on the related cellular events.
In rat thymocytes, the analogue dibutyryl cyclic GMP decreases basal 2-DG uptake [2] , and trypsin treatment results in some changes in the plasma membrane, but not in its permeability, as evident from the decrease in the binding of 3,3',5-tri-iodo-L-thyronine to its plasmamembrane receptors [3] . Hence, it is conceivable that the failure of trypsin to enhance sugar uptake in rat thymocytes results from a concomitant increase in cellular cyclic GMP, a decrease in the number of functional sugar transporters (which reside in the plasma membrane and are thought to be the principal vehicle through which D-glucose is transported into the cell [1] ), or both. To this end, I have examined here the effect of trypsin on cellular cyclic GMP concentration and on the number of sugar transporters.
Trypsin treatment did not change cellular cyclic GMP concentration, but it produced a progressive, doserelated, decrease in the number of functional sugar transporters in the thymocyte. From this I conclude that trypsin fails to increase 2-DG uptake in the rat thymocyte because its increase of cellular cyclic AMP concentration is accompanied by a decrease in the number of sugar transporters, responses that counterbalance one another.
EXPERIMENTAL

Materials
The materials used were purchased from the following sources: dibutyryl cyclic AMP, dibutyryl cyclic GMP and dimethyl sulphoxide from Sigma Chemical Co., St . Thymocytes were isolated as previously described [5] . In short, animals were killed by cervical dislocation, exsanguinated, and thymus glands were quickly removed, washed, and placed in ice-cold Krebs-Ringer-Tris buffer (20 mM-Tris/HCl, 5 mm-Tris base, 120 mM-NaCl, 5 mM-KCl, 1 mM-CaCl2, 2.5 mM-MgCl2, 1.5 mmNaH2PO4, 15 mM-Hepes), pH 7.4. Glands were then teased with forceps and the freed cells were filtered through a nylon mesh, centrifuged at 300 g for 15 min, and resuspended in the buffer to give the desired concentration.
Trypsin treatment of thymocytes
The suspended cells were transferred to a shaking water bath and were allowed to equilibrate for 15 min at 37°C in air. Then trypsin in various concentrations, ranging from 0.01 to 5 mg/ml, was added, and 15 min later the tryptic hydrolysis was stopped by the addition of soya-bean trypsin inhibitor (0.1-5 mg/ml). Soya-bean trypsin inhibitor added before trypsin abolished the effect of trypsin. Soya-bean trypsin inhibitor alone had no effect on the various cellular functions measured. This trypsin treatment transferred to plastic tubes and centrifuged at 1500 g for 2 min at 4 'C. Supernatants were removed and cell pellets were resuspended with 1.2 ml ofice-cold 5 % (w/v) trichloroacetic acid. Tubes were left in ice for 20 min and then centrifuged at 1500 g for 20 min. Supernatants were collected and their contents of cyclic AMP and cyclic GMP were measured by radioimmunoassay as previously described [1] .
Measurement of 13HI2-DG uptake Thymocytes (45 x 106 cells/ml) were first incubated with or without various concentrations of trypsin for 15 min. Trypsin treatment was terminated with the soya-bean inhibitor, and incubation continued for an additional 65 min. Then 1 ,uCi of [3H]2-DG/ml, in the presence or absence of various concentrations of unlabelled 2-DG, was added, and 15 min later its uptake by the cells was measured as previously described [5] . The experimental procedure for the measurement of [3H]2-DG uptake is the same as that used in previous studies, in which the effect of trypsin on thymocyte [3H]2-DG uptake was examined [3] . Under these conditions, [3H]2-DG uptake rate remains the same during the first 60 min of incubation; thus the 15 min incubation period with [3H]2-DG measures initial rates of sugar transport [5] . In measurements of the effect of Cyt B on thymocyte 2-DG uptake, cells were first incubated with various concentrations of Cyt B, and 30 min later 1 #uCi of [3H]2-DG/ml was added and its 15 min uptake was measured.
In comparable specimens, the extracellular marker [3H]mannitol (1 1sCi/ml) rather than [3H]2-DG was added, and its content in the 10000 g/30 s cell pellet was measured 5 min later as previously described [5] . 
Statistical analysis
Where appropriate, statistical analysis of differences between the experimental groups was assessed by analysis of variance, followed by the Newman-Keuls multiple range test for comparisons among multiple samples [6] .
RESULTS
Effect of trypsin treatment on cellular cyclic AMP and cyclic GMP concentrations Cells were treated with trypsin (concentrations 0.01-5 mg/ml) in the absence or presence of 5 mM-MIX. MIX produced a dose-dependent increase in both cyclic AMP and cyclic GMP concentration (results not shown). Maximal increase was seen at 5 mM-MIX: 8.8 + 0.9-fold for cyclic AMP and 5.6 + 0.6-fold for cyclic GMP. Trypsin, in the presence or absence of MIX, produced a dose-related increase in thymocyte cyclic AMP concentration ( Fig. 1) , and essentially the same proportionate increase in cyclic AMP was produced by trypsin in the presence or absence of the phosphodiesterase inhibitor. But trypsin, in the presence or absence of MIX, had no effect on thymocyte cyclic GMP concentration; cellular cyclic GMP concentration (pmol/108 cells; mean+S.D.) with and without 5 mM-MIX was 3.2 +0. 4 only at a concentration of 5 mg/ml did it produce a small, but significant, decrease in the sugar uptake (77 + 11 % of control, P < 0.05, n = 6; also see ref. [3] ).
The effect of trypsin treatment on the kinetic parameters of 2-DG uptake in the rat thymocyte was then measured. Here, an excellent correlation between trypsin-induced changes in SUI and sugar uptake was obtained, Where 5 mg of trypsin/ml decreased thymocyte 2-DG uptake by 22.7% and SUI by 21.1 %.
Effect of cytochalasin B on 2-deoxyglucose uptake Cyt B has been shown to inhibit D-glucose uptake in various tissues, presumably by competing with the sugar on the sugar-binding sites (sugar transporters) located in the plasma membrane [7] [8] [9] [10] [11] [12] . Here, in the rat thymocyte, Cyt B produced a marked dose-related decrease in [3H]2-DG uptake, so that at 10 jM-Cyt B [3H]2-DG uptake was virtually nil (Fig. 3) (Fig. 4) of [3H]Cyt B by the sugar-displaceable sites, so that at 0.3 mg of trypsin/ml, a concentration that produced almost maximal increase in cyclic AMP concentration, binding of Cyt B by the sugar-displaceable sites, i.e. the number of functional sugar transporters, was decreased by approx. 40 %, and was further decreased, to about 50%, at 5 mg of trypsin/ml.
Experiments were then conducted to assess the kinetic parameters of the binding of Cyt B by the sugardisplaceable sites in the rat thymocyte and the effect of trypsin thereupon. Binding of Cyt B by the sugardisplaceable sites was saturable, and again was decreased by trypsin (Fig. 7) an increase in sugar uptake [1, 2] . Additional studies have indicated that this observation is true provided that the cellular cyclic GMP concentration remains unchanged, because an increase in cyclic GMP concentration results in a decrease in thymocyte sugar uptake [2] . We have also demonstrated that trypsin increases thymocyte cyclic AMP concentration, but has no effect on 2-DG uptake [3, 4] , an observation which seemingly is inconsistent with our postulate. However, this could be explained as a result of a concomitant increase in cellular cyclic GMP concentration, or a proteolytic degradation of, and thereby a decrease in, the number of the plasmamembrane sugar transporters ofthe sugar-uptake system, or both (under the experimental conditions used, transport is the rate-limiting step in 2-DG uptake by the rat thymocyte [5] ). This is the subject of the present study.
Trypsin produced a dose-related increase in cellular cyclic AMP concentration, but failed to change cyclic GMP concentration in the rat thymocyte. Further, trypsin produced the same proportionate increase in cellular cyclic AMP concentration in the presence or absence of a maximally effective concentration of the phosphodiesterase inhibitor MIX, indicating that trypsin acted by increasing adenylate cyclase activity. This is consonant with other studies in the same and different tissues, in which trypsin has been suggested to increase adenylate cyclase activity [13] [14] [15] .
Trypsin failed to increase thymocyte 2-DG uptake, but at a concentration of 5 mg/ml it produced a small, significant, decrease in 2-DG uptake (-23% ; P < 0.05). Kinetic analysis of this effect of trypsin revealed that trypsin decreased both the Vmax and the affinity of the sugar-uptake system; 5 mg/ml of trypsin/ml decreased the SUI values by 21 %, which is consistent with its inhibition of 2-DG uptake.
As in many other systems [7] [8] [9] [10] [11] [12] [7, 11, [16] [17] [18] .
In the rat thymocyte, trypsin produced a concentration-dependent decrease in the binding of Cyt B by the functional sugar sites, owing to a decrease in the number of sugar transporters with no significant change in their affinity, so that a concentration of 0.3 mg of trypsin/ml, which produced about maximal increase in thymocyte cyclic AMP concentration, decreased the number of sugar transporters by about 40% (a further decrease was seen with 5 mg of trypsin/ml). Of interest are our previous studies in rat thymocytes [1] which show that dibutyryl cyclic AMP produces a dose-related increase in thymocyte [3H]2-DG uptake, having a maximal effect of about 40%.
This points to a good quantitative correlation between these two functions; thus 0.3 mg of trypsin/ml on the one hand produced a maximal increase in cellular cyclic AMP concentration, itself increasing 2-DG uptake by about 40%, whereas on the other hand it decreased the number of sugar transporters by about 40%, which accounts for the failure of trypsin (0.3 mg/ml) to change 2-DG uptake by the cell. The additional decrease in the number of the sugar transporters produced by 5 mg of trypsin/ml resulted in a decrease in 2-DG uptake.
The mechanism through which trypsin acts to decrease the number of functional sugar transporters located at the plasma membrane is not clear. Trypsin may do so by hydrolysing the functional plasmamembrane sugar transporters, or by enhancing the internalization of the transporters, or a combination of the two. Our studies in the rat thymocytes, which show that trypsin decreases the number of plasma membrane receptors for tri-iodothyronine, adrenaline and prostaglandin E1 [3] , favours the former, although the contribution of the latter cannot be excluded.
Hence, in freshly isolated rat thymocytes, trypsin produced an increase in cellular cyclic AMP concentration, with no effect on cyclic GMP concentration, that was accompanied by a decrease in the number of sugar transporters. Consequently, I suggest that the overall effect of trypsin on sugar uptake in the cell is the sum of the individual changes in cellular cyclic AMP concentration (positive) and in the number of functional sugar transporters (negative), which results in the failure of trypsin to increase sugar uptake in the rat thymocyte.
